Is self-administered DMPA an answer to contraception access in the post-Roe era?

IF 1.3 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Journal of Family Practice Pub Date : 2023-03-01 DOI:10.12788/jfp.0558

Lindsay Nakaishi, Gregory Castelli

引用次数: 0

Abstract

Compared with provider-administered depot medroxyprogesterone acetate, a prefilled formulation may offer patients improved access to effective contraception.

查看原文本刊更多论文

自我服用DMPA是后罗伊案件时代避孕途径的答案吗?

与供应商给药的醋酸甲孕酮相比，预充制剂可能为患者提供更有效的避孕方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Family Practice PRIMARY HEALTH CARE-MEDICINE, GENERAL & INTERNAL

CiteScore

0.50

自引率

0.00%

发文量

130

审稿时长

6-12 weeks

期刊介绍： JFP is a peer-reviewed medical journal specifically intended to meet the needs of the specialty of family medicine. JFP is delivered to more than 95,000 family physicians as well as general practitioners and osteopaths in primary care.